Salta al contenuto
PodcastMedicinaThe Lancet Infectious Diseases in conversation with

The Lancet Infectious Diseases in conversation with

The Lancet Group
The Lancet Infectious Diseases in conversation with
Ultimo episodio

127 episodi

  • The Lancet Infectious Diseases in conversation with

    Brecht Ingelbeen and Daniel Valia on a community-based antimicrobial stewardship intervention in Burkina Faso and DRC

    15/06/2026 | 26 min
    Dr Brecht Ingelbeen and Dr Daniel Valia join Senior Editor Phoebe Hall to discuss a new trial in the journal (the CABU-EICO trial) testing a co-created behavioural intervention bundle to improve antibiotic use, patient management, and water, sanitation and hygiene in rural communities in Burkina Faso and DR Congo.
    They explain why the study focused on community prescribing (not hospitals), the primary endpoint was a reduction in WHO AWaRE Watch antibiotics (not overall antibiotics), and the intervention targeted all providers of antibiotics in the community, including informal vendors.

    Finally, they discuss the importance of designing an intervention bundle that was truly tailored to local context yet practical, sustainable, and scalable beyond the study sites. A parallel study reporting the effect of the intervention bundle on ESBL-producing Escherichia coli colonisation (a co-primary outcome of the trial) is in press at The Lancet Microbe.  

    To read the full article:

    https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00169-6/fulltext

    The Lancet Infectious Diseases in conversation with...  is part of the Lancet Group podcast offering. 

    Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall

    Podcast editing: Matteo Simonetti

    Visit https://www.thelancet.com/multimedia to learn more about our multimedia offering. 

    Find the best science for better lives at lancet.com

    Follow us today at...
    https://thelancet.bsky.social/
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv
  • The Lancet Infectious Diseases in conversation with

    Sara Tartof and Matan Yechezkel on durability of doxycycline effectiveness against syphilis, gonorrhoea, and chlamydia after implementation of post-exposure prophylaxis in southern California

    07/05/2026 | 25 min
    Sara Tartof and Matan Yechezkel discuss a new article in The Lancet Infectious Diseases about emerging doxycycline resistance against gonorrhoea and its wider implications for the implementation of doxycycline and the prevention of bacterial sexually transmitted infections.

    Click here to read the full article:

    https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00123-4/fulltext

    The Lancet Infectious Diseases in conversation with...  is part of the Lancet Group podcast offering. 

    Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall

    Podcast editing: Matteo Simonetti

    Visit https://www.thelancet.com/multimedia to learn more about our multimedia offering. 

    Find the best science for better lives at lancet.com

    Follow us today at...
    https://thelancet.bsky.social/
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv
  • The Lancet Infectious Diseases in conversation with

    Jenny Clarke and Herve Semukunzi

    09/03/2026 | 20 min
    Dr Jenny Clarke and Herve Semukunzi discuss a study they and colleagues recently published with us  titled ‘Infection- and vaccine-induced mpox antibodies: validation of a combined mpox IgG ELISA during the clade 1b outbreak in Rwanda’. 

    They also discuss the reasons for the paucity of validated serological assays for mpox, particularly in outbreak regions where they are most urgently needed. 

    Click here to read the full article: 

    https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00006-X/fulltext

    Continue this conversation on social!
    Follow us today at...
    https://thelancet.bsky.social/
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    The Lancet Infectious Diseases in conversation with...  is part of the Lancet Group podcast offering. 

    Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall

    Podcast editing: Matteo Simonetti

    Visit https://www.thelancet.com/multimedia to learn more about our multimedia offering. 

    Find the best science for better lives at lancet.com

    Follow us today at...
    https://thelancet.bsky.social/
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv
  • The Lancet Infectious Diseases in conversation with

    Julia Moore Vogel and Danilo Buonsenso on long COVID

    19/12/2025 | 27 min
    Dr Julia Moore Vogel and Dr Danilo Buonsenso discuss various aspects of long COVID including epidemiology, pathophysiology, underlying mechanisms, management, latest research developments, difficulties in conducting clinical trials, and future research priorities.

    Continue this conversation on social!
    Follow us today at...
    https://thelancet.bsky.social/
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    The Lancet Infectious Diseases in conversation with...  is part of the Lancet Group podcast offering. 

    Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall

    Podcast editing: Matteo Simonetti

    Visit https://www.thelancet.com/multimedia to learn more about our multimedia offering. 

    Find the best science for better lives at lancet.com

    Follow us today at...
    https://thelancet.bsky.social/
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv
  • The Lancet Infectious Diseases in conversation with

    In Conversation with Steven Tong and Joshua Davis on adaptive platform trials

    23/10/2025 | 25 min
    Professors Steven Tong and Joshua Davis discuss all aspects of adaptive platform trials including advantages, disadvantages, differences from conventional trials, and tips for setting up and assessing them.

    They also highlight several adaptive platform trials currently in the pipeline that could influence infectious disease clinical practise in the future.

    Click here to read our latest issue

    Continue this conversation on social!
    Follow us today at...
    https://thelancet.bsky.social/
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    The Lancet Infectious Diseases in conversation with...  is part of the Lancet Group podcast offering. 

    Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall

    Podcast editing: Matteo Simonetti

    Visit https://www.thelancet.com/multimedia to learn more about our multimedia offering. 

    Find the best science for better lives at lancet.com

    Follow us today at...
    https://thelancet.bsky.social/
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv
Altri podcast di Medicina
Su The Lancet Infectious Diseases in conversation with
The editorial team of The Lancet Infectious Diseases, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy. An audio companion to the journal, this podcast covers a broad range of topics, from mpox diagnostics in Africa, long COVID, adaptive trials in infectious diseases, tuberculosis drug development, and more.
Sito web del podcast

Ascolta The Lancet Infectious Diseases in conversation with, The Peter Attia Drive e molti altri podcast da tutto il mondo con l’applicazione di radio.it

Scarica l'app gratuita radio.it

  • Salva le radio e i podcast favoriti
  • Streaming via Wi-Fi o Bluetooth
  • Supporta Carplay & Android Auto
  • Molte altre funzioni dell'app
The Lancet Infectious Diseases in conversation with: Podcast correlati
  • Podcast The Lancet Psychiatry in conversation with
    The Lancet Psychiatry in conversation with
    Medicina, Salute e benessere